CH Biotech R&D Co., Ltd. (TPE:6534)
119.00
+0.50 (0.42%)
Sep 1, 2025, 9:52 AM CST
CH Biotech R&D Revenue
CH Biotech R&D had revenue of 420.48M TWD in the quarter ending June 30, 2025, with 4.93% growth. This brings the company's revenue in the last twelve months to 1.68B, up 13.79% year-over-year. In the year 2024, CH Biotech R&D had annual revenue of 1.64B with 7.98% growth.
Revenue (ttm)
1.68B
Revenue Growth
+13.79%
P/S Ratio
7.23
Revenue / Employee
n/a
Employees
n/a
Market Cap
12.18B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.64B | 120.91M | 7.98% |
Dec 31, 2023 | 1.51B | 80.71M | 5.63% |
Dec 31, 2022 | 1.43B | 415.61M | 40.81% |
Dec 31, 2021 | 1.02B | 316.32M | 45.05% |
Dec 31, 2020 | 702.19M | -138.49M | -16.47% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nan Ya Plastics | 265.84B |
China Steel | 340.48B |
Formosa Plastics | 193.41B |
Formosa Chemicals & Fibre | 320.65B |
TCC Group Holdings | 160.40B |
Asia Cement | 76.07B |
Taiwan Glass Ind. | 41.64B |
Walsin Lihwa | 181.73B |